Diaclone Recombinant Antibodies

 

Over the years, we have invested in recombinant antibody technologies to complete our range of monoclonal antibodies. Alongside our monoclonal antibody development platform by conventional hybridoma technology, Diaclone is now able to develop recombinant antibodies by optimized Phage Display technology.

A good example is our B-B49 clone (anti-IL-8).

Diaclone also benefits from the technical expertise and support of its sister company RD-Biotech for the development of recombinant antibodies by molecular engineering and humanization technologies.

Recombinant antibodies are developed in our laboratories for a wide range of applications (Flow Cytometry, Immunohistochemistry, Western Blot, Immunoprecipitation, ELISA, ELISpot and Biological assays …)

Standard sizes and Bulk formats available.

Description

Target species

Clone

Synonym

Read more

Anti-Human CD141 Azide Free

Human

B-S24

Thrombomodulin

Detail

Anti-Human CD141 Detection Antibody

Human

B-S24

Thrombomodulin

Detail

Anti-Human IL-1β Azide Free

Human

B-A15

IL-1b, IL-1beta

Detail

Anti-Human IL-1β PE Conjugated

Human

B-A15

IL-1b, IL-1beta

Detail

Anti-Human IL-23 Azide Free

Human

B-F43

 

Detail

Anti-Human IL-23 Detection Antibody

Human

B-F43

 

Detail

Anti-Human IL-8 Azide Free

Human

B-B49

CXCL8

Detail

Anti-SARS-CoV-2 Nucleoprotein Azide Free

SARS-CoV-2

CR3018

Nucleoprotein, SARS-CoV nucleoprotein, Nucleocapsid protein

Detail

Anti-SARS-CoV-2 Spike S1 Protein Azide Free

SARS-CoV-2

CR3022-IgG

Receptor binding domain Spike protein, RBD spike protein

Detail

Anti-SARS-CoV-2 Spike S1 Protein Azide Free (IgA)

SARS-CoV-2

CR3022-IgA

Receptor binding domain Spike protein, RBD spike protein

Detail

Product search